home / stock / amrx / amrx news


AMRX News and Press, Amneal Pharmaceuticals Inc. Class A From 03/11/19

Stock Information

Company Name: Amneal Pharmaceuticals Inc. Class A
Stock Symbol: AMRX
Market: NASDAQ
Website: amneal.com

Menu

AMRX AMRX Quote AMRX Short AMRX News AMRX Articles AMRX Message Board
Get AMRX Alerts

News, Short Squeeze, Breakout and More Instantly...

AMRX - Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q4 2018 Update

This article is part of a series that provides an ongoing analysis of the changes made to Ole Andreas Halvorsen’s 13F stock portfolio on a quarterly basis. It is based on Viking Global’s regulatory 13F Form filed on 02/14/2019. Please visit our Tracking Ole Andreas Halvorsen&#...

AMRX - Amneal Pharmaceuticals to Present at the Barclays Global Healthcare Conference

BRIDGEWATER, N.J. , March 6, 2019 /PRNewswire/ -- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) today announced that members of management will participate in a fireside chat at the Barclays Global Healthcare Conference at the Loews Miami Beach Hotel in Miami on Wednesday, March 13, 2019 ....

AMRX - Amneal Pharmaceuticals, Inc (AMRX) CEO Rob Stewart on Q4 2018 Results - Earnings Call Transcript

Amneal Pharmaceuticals, Inc. (AMRX) Q4 2018 Results Earnings Conference Call February 28, 2019, 08:30 AM ET Company Participants Mark Donohue - Vice President, Investor Relations and Corporate Communications Rob Stewart - President and Chief Executive Officer Todd Branning - Chie...

AMRX - Amneal Pharmaceuticals, Inc. 2018 Q4 - Results - Earnings Call Slides

The following slide deck was published by Amneal Pharmaceuticals, Inc. in conjunction with their 2018 Q4 earnings Read more ...

AMRX - Amneal Pharmaceuticals beats by $0.06, beats on revenue

Amneal Pharmaceuticals (NYSE: AMRX ): Q4 Non-GAAP EPS of $0.33 beats by $0.06 ; GAAP EPS of -$0.07 misses by $0.32 . More news on: Amneal Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

AMRX - Amneal Reports Fourth Quarter And Full Year 2018 Financial Results

BRIDGEWATER, N.J. , Feb. 28, 2019 /PRNewswire/ --  Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (the "Company") announced its results today for the fourth quarter and year ended December 31, 2018 .         Executive Commentary "We ended a year o...

AMRX - Notable earnings before Thursday's open

AAON , ABB , ACIW , AKRX , AMCX , AMRX , BCPC , BID , BMCH , BPMP , BUD , CARS , CM , CMD , CNP , CROX , CWEN , CWT , DAVA , DEA , EGRX , ENDP , EXLS , FOLD , FRO , FSS , GOLF , GTN , GTT , HMHC , HRI , IBP , ICPT , IRDM , JCP , JD , KDP , LAUR , LKQ ,...

AMRX - Amneal to Report Fourth Quarter and Full Year 2018 Results on February 28, 2019

BRIDGEWATER, N.J. , Jan. 24, 2019 /PRNewswire/ --  Amneal Pharmaceuticals, Inc. (NYSE: AMRX)  announced today that the Company will release its fourth quarter and full year 2018 financial results on Thursday, February 28, 2019 , prior to the open of the U.S. financial markets. ...

Previous 10 Next 10